11-119096814-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001382.4(DPAGT1):​c.*184G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 719,004 control chromosomes in the GnomAD database, including 66,477 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12042 hom., cov: 32)
Exomes 𝑓: 0.43 ( 54435 hom. )

Consequence

DPAGT1
NM_001382.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.195

Publications

21 publications found
Variant links:
Genes affected
DPAGT1 (HGNC:2995): (dolichyl-phosphate N-acetylglucosaminephosphotransferase 1) The protein encoded by this gene is an enzyme that catalyzes the first step in the dolichol-linked oligosaccharide pathway for glycoprotein biosynthesis. This enzyme belongs to the glycosyltransferase family 4. This protein is an integral membrane protein of the endoplasmic reticulum. The congenital disorder of glycosylation type Ij is caused by mutation in the gene encoding this enzyme. [provided by RefSeq, Jul 2008]
DPAGT1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
  • DPAGT1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.624 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DPAGT1NM_001382.4 linkc.*184G>A 3_prime_UTR_variant Exon 9 of 9 ENST00000354202.9 NP_001373.2 Q9H3H5-1A0A024R3H8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DPAGT1ENST00000354202.9 linkc.*184G>A 3_prime_UTR_variant Exon 9 of 9 1 NM_001382.4 ENSP00000346142.4 Q9H3H5-1

Frequencies

GnomAD3 genomes
AF:
0.388
AC:
58869
AN:
151786
Hom.:
12031
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.290
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.329
Gnomad ASJ
AF:
0.534
Gnomad EAS
AF:
0.641
Gnomad SAS
AF:
0.517
Gnomad FIN
AF:
0.393
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.422
Gnomad OTH
AF:
0.421
GnomAD4 exome
AF:
0.430
AC:
243846
AN:
567100
Hom.:
54435
Cov.:
7
AF XY:
0.436
AC XY:
130835
AN XY:
300336
show subpopulations
African (AFR)
AF:
0.285
AC:
4295
AN:
15076
American (AMR)
AF:
0.271
AC:
7619
AN:
28120
Ashkenazi Jewish (ASJ)
AF:
0.550
AC:
9282
AN:
16872
East Asian (EAS)
AF:
0.621
AC:
19749
AN:
31796
South Asian (SAS)
AF:
0.498
AC:
26969
AN:
54148
European-Finnish (FIN)
AF:
0.384
AC:
14247
AN:
37110
Middle Eastern (MID)
AF:
0.466
AC:
1083
AN:
2324
European-Non Finnish (NFE)
AF:
0.419
AC:
147391
AN:
351412
Other (OTH)
AF:
0.437
AC:
13211
AN:
30242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
7465
14931
22396
29862
37327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1590
3180
4770
6360
7950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.388
AC:
58905
AN:
151904
Hom.:
12042
Cov.:
32
AF XY:
0.390
AC XY:
28980
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.290
AC:
11986
AN:
41388
American (AMR)
AF:
0.328
AC:
5009
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.534
AC:
1851
AN:
3466
East Asian (EAS)
AF:
0.642
AC:
3306
AN:
5146
South Asian (SAS)
AF:
0.516
AC:
2486
AN:
4822
European-Finnish (FIN)
AF:
0.393
AC:
4154
AN:
10560
Middle Eastern (MID)
AF:
0.421
AC:
123
AN:
292
European-Non Finnish (NFE)
AF:
0.422
AC:
28650
AN:
67950
Other (OTH)
AF:
0.425
AC:
897
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1786
3572
5359
7145
8931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.398
Hom.:
7709
Bravo
AF:
0.378
Asia WGS
AF:
0.542
AC:
1889
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Acute intermittent porphyria Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DPAGT1-congenital disorder of glycosylation Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.26
DANN
Benign
0.36
PhyloP100
-0.20
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8551; hg19: chr11-118967524; COSMIC: COSV53830464; COSMIC: COSV53830464; API